+Follow
jac_tb
No personal profile
3
Follow
5
Followers
0
Topic
0
Badge
Posts
Hot
jac_tb
2021-09-11
$Clover Health Corp(CLOV)$
regret not taking profit when it rose to 11+
jac_tb
2021-09-11
$Clover Health Corp(CLOV)$
.
jac_tb
2021-09-11
.
Why AMC, Clover, and Other Meme Stocks Tumbled On Wednesday
jac_tb
2021-08-29
$H&R Block(HRB)$
.
jac_tb
2021-08-29
.
This Unloved Tech Stock Could Make You Rich One Day
jac_tb
2021-08-21
$Clover Health Corp(CLOV)$
Aim where?
jac_tb
2021-08-21
Will it sell on news....
Pfizer, BioNTech stocks rises on report FDA could fully approve COVID-19 vaccine
jac_tb
2021-08-20
Time will tell.... but by then, the answer may have come too late.
Sorry, the original content has been removed
jac_tb
2021-06-29
.
Sorry, the original content has been removed
jac_tb
2021-06-29
Waiting for ORPH
Sorry, the original content has been removed
jac_tb
2021-06-29
$Bsquare Corp(BSQR)$
go go go!
jac_tb
2021-06-25
.
Sorry, the original content has been removed
jac_tb
2021-06-25
$Bsquare Corp(BSQR)$
step by step
jac_tb
2021-06-13
.
Sorry, the original content has been removed
jac_tb
2021-06-07
$Bsquare Corp(BSQR)$
first time buying this stock? What is its play like? Any potential target?
jac_tb
2021-06-05
$Bsquare Corp(BSQR)$
any idea why sudden volume?
jac_tb
2021-06-01
$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$
been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?
jac_tb
2021-05-30
What's the next meme stock? Missed it this time.
Sorry, the original content has been removed
jac_tb
2021-05-29
Nice write up. Keeping the faith with Lucid.
Sorry, the original content has been removed
jac_tb
2021-05-26
$Microvision(MVIS)$
Will we see another day of push today? Hope to see it break $16 and move further up.
Go to Tiger App to see more news
Invest in Global Markets with Tiger Brokers!
Open App
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3565449260630555","uuid":"3565449260630555","gmtCreate":1602355275444,"gmtModify":1615046426768,"name":"jac_tb","pinyin":"jactbjactb","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":3,"tweetSize":60,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.05%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":881542725,"gmtCreate":1631370487667,"gmtModify":1676530536939,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","text":"$Clover Health Corp(CLOV)$regret not taking profit when it rose to 11+","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/881542725","isVote":1,"tweetType":1,"viewCount":1655,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554171307804467","authorId":"3554171307804467","name":"不轻易买股票","avatar":"https://static.tigerbbs.com/9591045ed55f6fad3186a4cd347989e0","crmLevel":1,"crmLevelSwitch":0,"idStr":"3554171307804467","authorIdStr":"3554171307804467"},"content":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","text":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","html":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881542214,"gmtCreate":1631370455638,"gmtModify":1676530536930,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>.","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>.","text":"$Clover Health Corp(CLOV)$.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881542214","isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881542123,"gmtCreate":1631370418862,"gmtModify":1676530536926,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881542123","repostId":"1174332657","repostType":2,"repost":{"id":"1174332657","kind":"news","pubTimestamp":1631168952,"share":"https://ttm.financial/m/news/1174332657?lang=&edition=full_marsco","pubTime":"2021-09-09 14:29","market":"us","language":"en","title":"Why AMC, Clover, and Other Meme Stocks Tumbled On Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1174332657","media":"Motley Fool","summary":"The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at some point, people will want to take profits.","content":"<html><body><p>The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at some point, people will want to take profits.</p>\n<p><b>What happened</b></p>\n<p>Shares of <b>AMC Entertainment Holdings</b>(NYSE:AMC),<b>Skillz</b>(NYSE:SKLZ), and <b>Tonix Pharmaceuticals</b>(NASDAQ:TNXP) fell 0.9%, 8.3%, and 4.2% as of closed on Wednesday, with the fickle meme stock trading crowd reversing recent bullishness. Leading the charge for today's rout, however, is <b>Clover Health Investments</b>(NASDAQ:CLOV), down 12.5%.</p>\n<p><b>So what</b></p>\n<p>If you're looking for the headlines behind the moves, don't bother. There aren't any.</p>\n<p>As has been the case for the past few months, traders looking for a speculative edge are simply gathering around these stocks in an effort to collectively create the price action they desire, often by creating memes regarding these companies. Such efforts cause incredible price volatility.</p>\n<p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/3ba4680fa5e89ea08b364002d70d086f\" tg-height=\"1201\" tg-width=\"2000\" width=\"100%\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p>Many of these names -- like Clover this week -- have also been recently targeted as short-squeeze candidates. That's not a terribly bad bet right now either, to be fair, in that more than 7% of the outstanding shares of the health insurance company are currently tied up in short trades. That's enough short positions to prospectively spark en masse buying that drives the price sharply higher,<i>if</i>those short-sellers start becoming unnerved by a bit of bullishness. Tuesday's 15% jump for Clover shares didn't do the trick, however, with most of that gain being given back today.</p>\n<p>Shares of movie theater chain AMC Entertainment aren't really helping the broader bullish effort either. While one would expect this king of all meme stocks to soar following reports of record-breaking Labor Day weekend box office ticket sales, a bit of Tuesday's near-9% gain from AMC shares is also unwinding with Wednesday's1% sell-off. While that's hardly a devastating setback, the failure to follow through on Tuesday's advance is telling in and of itself.</p>\n<p>Of course, the broad market's sell-off today is also creating a headwind for these well-known meme stocks.</p>\n<p><b>Now what</b></p>\n<p>The advent of meme stock mania (and in particular, organized efforts to spark short squeezes) comes as no real surprise. If you give enough people enough time and the means of doing so, it's reasonable to expect them to capitalize on an opportunity -- including one they must plan out on one of the internet's more popular message boards. A little success on this front early this year prompted the trading crowd to replicate the effort.</p>\n<p>Regardless of the strategy's previous effectiveness, however, meme stock mania is losing steam. Not only are hedge funds and other managed investment pools now shoring up their risk exposure to short squeezes, traders are also running out of stocks they can push around.</p>\n<p>They're also running out of other buyers and bullish arguments.</p>\n<p>See, for most meme stocks to continue their rallies, new buyers must bring new money to the table to purchase shares from traders that have already scooped up the stock and are now looking to lock in a sizable profit. Enough people were willing to take such a swing early in the year when AMC was trading around $2 per share. Now that it's trading at more than $46 per share, however, would-be buyers are considerably less interested. Underscoring this idea is the fact that shares of Tonix Pharmaceuticals and Clover Health have yet to respond to the same rally driving strategies that -- at least for a while -- buoyed AMC stock. In a similar vein, Skillz shares have also stopped responding to the bullish prompts that drove the stock from around $11 per share in November of last year to February's high in excess of $46. They're now back near $11, unable to keep a rally going.</p>\n<p>There's something of a litmus test for the entire meme stock movement due this afternoon. Another meme stock company,<b>GameStop</b>(NYSE:GME), is slated to report its fiscal second-quarter numbers after today's closing bell rings. The numbers are important. But even more important is whether or not the trading crowd relaying on the web's popular message boards will be able to convince others to start and sustain a rally from GameStop. If it can, other meme stocks like AMC and Clover will remain at least somewhat in play. If it can't, it may well be a sign that the underlying strategy of individual traders targeting one ticker at a time is no longer effective. This in turn may sour most of them from even trying to do so, continuing the conversion of many of these meme names back to more conventionally priced stocks.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Why AMC, Clover, and Other Meme Stocks Tumbled On Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AMC, Clover, and Other Meme Stocks Tumbled On Wednesday\n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-09 14:29 GMT+8 <a href=\"https://www.fool.com/investing/2021/09/08/why-amc-clover-and-other-meme-stocks-are-tumbling/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at ...</p>\n<a href=\"https://www.fool.com/investing/2021/09/08/why-amc-clover-and-other-meme-stocks-are-tumbling/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/09/08/why-amc-clover-and-other-meme-stocks-are-tumbling/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174332657","content_text":"The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value. And, at some point, people will want to take profits.\nWhat happened\nShares of AMC Entertainment Holdings(NYSE:AMC),Skillz(NYSE:SKLZ), and Tonix Pharmaceuticals(NASDAQ:TNXP) fell 0.9%, 8.3%, and 4.2% as of closed on Wednesday, with the fickle meme stock trading crowd reversing recent bullishness. Leading the charge for today's rout, however, is Clover Health Investments(NASDAQ:CLOV), down 12.5%.\nSo what\nIf you're looking for the headlines behind the moves, don't bother. There aren't any.\nAs has been the case for the past few months, traders looking for a speculative edge are simply gathering around these stocks in an effort to collectively create the price action they desire, often by creating memes regarding these companies. Such efforts cause incredible price volatility.\nIMAGE SOURCE: GETTY IMAGES.\nMany of these names -- like Clover this week -- have also been recently targeted as short-squeeze candidates. That's not a terribly bad bet right now either, to be fair, in that more than 7% of the outstanding shares of the health insurance company are currently tied up in short trades. That's enough short positions to prospectively spark en masse buying that drives the price sharply higher,ifthose short-sellers start becoming unnerved by a bit of bullishness. Tuesday's 15% jump for Clover shares didn't do the trick, however, with most of that gain being given back today.\nShares of movie theater chain AMC Entertainment aren't really helping the broader bullish effort either. While one would expect this king of all meme stocks to soar following reports of record-breaking Labor Day weekend box office ticket sales, a bit of Tuesday's near-9% gain from AMC shares is also unwinding with Wednesday's1% sell-off. While that's hardly a devastating setback, the failure to follow through on Tuesday's advance is telling in and of itself.\nOf course, the broad market's sell-off today is also creating a headwind for these well-known meme stocks.\nNow what\nThe advent of meme stock mania (and in particular, organized efforts to spark short squeezes) comes as no real surprise. If you give enough people enough time and the means of doing so, it's reasonable to expect them to capitalize on an opportunity -- including one they must plan out on one of the internet's more popular message boards. A little success on this front early this year prompted the trading crowd to replicate the effort.\nRegardless of the strategy's previous effectiveness, however, meme stock mania is losing steam. Not only are hedge funds and other managed investment pools now shoring up their risk exposure to short squeezes, traders are also running out of stocks they can push around.\nThey're also running out of other buyers and bullish arguments.\nSee, for most meme stocks to continue their rallies, new buyers must bring new money to the table to purchase shares from traders that have already scooped up the stock and are now looking to lock in a sizable profit. Enough people were willing to take such a swing early in the year when AMC was trading around $2 per share. Now that it's trading at more than $46 per share, however, would-be buyers are considerably less interested. Underscoring this idea is the fact that shares of Tonix Pharmaceuticals and Clover Health have yet to respond to the same rally driving strategies that -- at least for a while -- buoyed AMC stock. In a similar vein, Skillz shares have also stopped responding to the bullish prompts that drove the stock from around $11 per share in November of last year to February's high in excess of $46. They're now back near $11, unable to keep a rally going.\nThere's something of a litmus test for the entire meme stock movement due this afternoon. Another meme stock company,GameStop(NYSE:GME), is slated to report its fiscal second-quarter numbers after today's closing bell rings. The numbers are important. But even more important is whether or not the trading crowd relaying on the web's popular message boards will be able to convince others to start and sustain a rally from GameStop. If it can, other meme stocks like AMC and Clover will remain at least somewhat in play. If it can't, it may well be a sign that the underlying strategy of individual traders targeting one ticker at a time is no longer effective. This in turn may sour most of them from even trying to do so, continuing the conversion of many of these meme names back to more conventionally priced stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":948,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813773882,"gmtCreate":1630259886746,"gmtModify":1676530251846,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HRB\">$H&R Block(HRB)$</a>.","listText":"<a href=\"https://laohu8.com/S/HRB\">$H&R Block(HRB)$</a>.","text":"$H&R Block(HRB)$.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813773882","isVote":1,"tweetType":1,"viewCount":934,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813773363,"gmtCreate":1630259850052,"gmtModify":1676530251863,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813773363","repostId":"1129129956","repostType":4,"repost":{"id":"1129129956","kind":"news","pubTimestamp":1630201285,"share":"https://ttm.financial/m/news/1129129956?lang=&edition=full_marsco","pubTime":"2021-08-29 09:41","market":"us","language":"en","title":"This Unloved Tech Stock Could Make You Rich One Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1129129956","media":"Motley Fool","summary":"The iBuying business is a race to grow larger, and Opendoor is winning.The company is growing at a rate that is two years ahead of what management projected just a year earlier.The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.Real estate iBuying company Opendoor Technologieshas been executing at a high level in the three quarters since coming public via a special purpose acquisition company merger. In a race to disrupt residential ","content":"<html><body><p>Key Points</p>\n<ul>\n<li>The iBuying business is a race to grow larger, and Opendoor is winning.</li>\n<li>The company is growing at a rate that is two years ahead of what management projected just a year earlier.</li>\n<li>The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.</li>\n</ul>\n<p></p>\n<p>Real estate iBuying company <b>Opendoor Technologies</b>(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.</p>\n<p>Despite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.</p>\n<h3>1. Opendoor is winning the iBuying battle</h3>\n<p>The traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.</p>\n<p>Opendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.</p>\n<p>After seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including <b>Zillow Group</b> and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.</p>\n<p>According to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.</p>\n<h3>2. Revenue growth is ahead of schedule</h3>\n<p>When companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.</p>\n<p>Fast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"</p>\n<p>In other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.</p>\n<h3>3. SPACs are out of favor with the market... opportunity?</h3>\n<p>Investors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.</p>\n<p>Investors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.</p>\n<p>But if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.</p>\n<p>Competitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.</p>\n<h3>Here's the bottom line</h3>\n<p>Real estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"<b>Amazon</b>\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.</p>\n<p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>This Unloved Tech Stock Could Make You Rich One Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Unloved Tech Stock Could Make You Rich One Day\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-29 09:41 GMT+8 <a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe ...</p>\n<a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPEN":"Opendoor Technologies Inc"},"source_url":"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129129956","content_text":"Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.\n\n\nReal estate iBuying company Opendoor Technologies(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.\nDespite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.\n1. Opendoor is winning the iBuying battle\nThe traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.\nOpendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.\nAfter seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including Zillow Group and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.\nAccording to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.\n2. Revenue growth is ahead of schedule\nWhen companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.\nFast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"\nIn other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.\n3. SPACs are out of favor with the market... opportunity?\nInvestors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.\nInvestors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.\nBut if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.\nCompetitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.\nHere's the bottom line\nReal estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"Amazon\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.","news_type":1},"isVote":1,"tweetType":1,"viewCount":767,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836430809,"gmtCreate":1629512793401,"gmtModify":1676530062423,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Aim where?","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Aim where?","text":"$Clover Health Corp(CLOV)$Aim where?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836430809","isVote":1,"tweetType":1,"viewCount":1143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836494103,"gmtCreate":1629512656802,"gmtModify":1676530062384,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"Will it sell on news....","listText":"Will it sell on news....","text":"Will it sell on news....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836494103","repostId":"2161745179","repostType":4,"repost":{"id":"2161745179","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1629500040,"share":"https://ttm.financial/m/news/2161745179?lang=&edition=full_marsco","pubTime":"2021-08-21 06:54","market":"us","language":"en","title":"Pfizer, BioNTech stocks rises on report FDA could fully approve COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2161745179","media":"Dow Jones","summary":"Pfizer Inc. $(PFE)$ and U.S. shares of BioNTech SE (BNTX) rose in the extended session Friday follow","content":"<html><body><p>Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and U.S. shares of <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (BNTX) rose in the extended session Friday following a report that the drug makers will likely get full Food and Drug Administration approval for their COVID-19 vaccine sometime next week. Pfizer shares rose more than 2% after hours, following a 0.2% decline to close at $48.72, and BioNTech's ADRs rallied more than 5%, following a 5.1% gain to close at $348.68. Late Friday, The New York Times reported targeting the delta variant of the virus.</p>\n<p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Pfizer, BioNTech stocks rises on report FDA could fully approve COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech stocks rises on report FDA could fully approve COVID-19 vaccine\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-21 06:54</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and U.S. shares of <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (BNTX) rose in the extended session Friday following a report that the drug makers will likely get full Food and Drug Administration approval for their COVID-19 vaccine sometime next week. Pfizer shares rose more than 2% after hours, following a 0.2% decline to close at $48.72, and BioNTech's ADRs rallied more than 5%, following a 5.1% gain to close at $348.68. Late Friday, The New York Times reported targeting the delta variant of the virus.</p>\n<p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161745179","content_text":"Pfizer Inc. $(PFE)$ and U.S. shares of BioNTech SE (BNTX) rose in the extended session Friday following a report that the drug makers will likely get full Food and Drug Administration approval for their COVID-19 vaccine sometime next week. Pfizer shares rose more than 2% after hours, following a 0.2% decline to close at $48.72, and BioNTech's ADRs rallied more than 5%, following a 5.1% gain to close at $348.68. Late Friday, The New York Times reported targeting the delta variant of the virus.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1012,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836673146,"gmtCreate":1629484466485,"gmtModify":1676530056465,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"Time will tell.... but by then, the answer may have come too late.","listText":"Time will tell.... but by then, the answer may have come too late.","text":"Time will tell.... but by then, the answer may have come too late.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836673146","repostId":"2160710721","repostType":4,"isVote":1,"tweetType":1,"viewCount":1095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159847038,"gmtCreate":1624958412124,"gmtModify":1703848829475,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159847038","repostId":"2147832042","repostType":4,"isVote":1,"tweetType":1,"viewCount":825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159842799,"gmtCreate":1624958280911,"gmtModify":1703848831740,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"Waiting for ORPH","listText":"Waiting for ORPH","text":"Waiting for ORPH","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159842799","repostId":"1104222469","repostType":4,"isVote":1,"tweetType":1,"viewCount":760,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159849194,"gmtCreate":1624957974818,"gmtModify":1703848819115,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>go go go!","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>go go go!","text":"$Bsquare Corp(BSQR)$go go go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159849194","isVote":1,"tweetType":1,"viewCount":309,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126542274,"gmtCreate":1624579973398,"gmtModify":1703840734118,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126542274","repostId":"1160256327","repostType":4,"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126546812,"gmtCreate":1624579943836,"gmtModify":1703840730039,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>step by step","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>step by step","text":"$Bsquare Corp(BSQR)$step by step","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126546812","isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182345922,"gmtCreate":1623555615766,"gmtModify":1704206058554,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182345922","repostId":"2143178871","repostType":4,"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114599550,"gmtCreate":1623078376870,"gmtModify":1704195677777,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","text":"$Bsquare Corp(BSQR)$first time buying this stock? What is its play like? Any potential target?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/114599550","isVote":1,"tweetType":1,"viewCount":1117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":112897495,"gmtCreate":1622859268917,"gmtModify":1704192561355,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>any idea why sudden volume?","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>any idea why sudden volume?","text":"$Bsquare Corp(BSQR)$any idea why sudden volume?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/112897495","isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119656923,"gmtCreate":1622544455262,"gmtModify":1704185988030,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","listText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119656923","isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137445062,"gmtCreate":1622382951456,"gmtModify":1704183686735,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"What's the next meme stock? Missed it this time.","listText":"What's the next meme stock? Missed it this time.","text":"What's the next meme stock? Missed it this time.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/137445062","repostId":"2138929107","repostType":4,"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134757942,"gmtCreate":1622262357586,"gmtModify":1704182469619,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"Nice write up. Keeping the faith with Lucid.","listText":"Nice write up. Keeping the faith with Lucid.","text":"Nice write up. Keeping the faith with Lucid.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134757942","repostId":"2138102985","repostType":2,"isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136510064,"gmtCreate":1622027236558,"gmtModify":1704178077260,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565449260630555","authorIdStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Will we see another day of push today? Hope to see it break $16 and move further up.","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Will we see another day of push today? Hope to see it break $16 and move further up.","text":"$Microvision(MVIS)$Will we see another day of push today? Hope to see it break $16 and move further up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/136510064","isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":836494103,"gmtCreate":1629512656802,"gmtModify":1676530062384,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"Will it sell on news....","listText":"Will it sell on news....","text":"Will it sell on news....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836494103","repostId":"2161745179","repostType":4,"isVote":1,"tweetType":1,"viewCount":1012,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881542725,"gmtCreate":1631370487667,"gmtModify":1676530536939,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>regret not taking profit when it rose to 11+","text":"$Clover Health Corp(CLOV)$regret not taking profit when it rose to 11+","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/881542725","isVote":1,"tweetType":1,"viewCount":1655,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554171307804467","authorId":"3554171307804467","name":"不轻易买股票","avatar":"https://static.tigerbbs.com/9591045ed55f6fad3186a4cd347989e0","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3554171307804467","idStr":"3554171307804467"},"content":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","text":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks.","html":"I have risen to 28, and it is too early to regret 11 pieces. I have no regrets. I am an adult. I regret not selling early, and I regret not selling. I am not happy to earn or lose money. I am not happy to play any stocks."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836673146,"gmtCreate":1629484466485,"gmtModify":1676530056465,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"Time will tell.... but by then, the answer may have come too late.","listText":"Time will tell.... but by then, the answer may have come too late.","text":"Time will tell.... but by then, the answer may have come too late.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836673146","repostId":"2160710721","repostType":4,"repost":{"id":"2160710721","kind":"news","pubTimestamp":1629473265,"share":"https://ttm.financial/m/news/2160710721?lang=&edition=full_marsco","pubTime":"2021-08-20 23:27","market":"us","language":"en","title":"Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?","url":"https://stock-news.laohu8.com/highlight/detail?id=2160710721","media":"Zacks","summary":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. ","content":"<html><body><p><b>Moderna</b>’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a <a href=\"https://laohu8.com/S/WASH\">Washington</a> <a href=\"https://laohu8.com/S/POST\">Post</a> article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>/<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>’s mRNA-based vaccine, BNT162b.</p>\n<p>Per the same <a href=\"https://laohu8.com/S/WRE\">Washington</a> Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.</p>\n<p>We note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.</p>\n<p>Meanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.</p>\n<p>Shares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.</p>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/01ae6084260e85bc39bcd6d72d8d9ae0\" tg-height=\"406\" tg-width=\"620\"/></p>\n<p>Image Source: Zacks Investment Research</p>\n<p>We note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with <b>J&J</b>’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.</p>\n<p>Meanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination. The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).</p>\n<h3><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> Price</h3>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/33512fafdd460236be3b7bc6e113462a\" tg-height=\"257\" tg-width=\"545\"/></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> price | Moderna, Inc. Quote</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-20 23:27 GMT+8 <a href=\"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html\"><strong>Zacks</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of...</p>\n<a href=\"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2160710721","content_text":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a Washington Post article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than Pfizer/BioNTech SE’s mRNA-based vaccine, BNT162b.\nPer the same Washington Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the United States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.\nWe note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.\nMeanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.\nShares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.\n\nImage Source: Zacks Investment Research\nWe note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.\nMeanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination. The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).\nModerna, Inc. Price\n\nModerna, Inc. price | Moderna, Inc. Quote","news_type":1},"isVote":1,"tweetType":1,"viewCount":1095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114599550,"gmtCreate":1623078376870,"gmtModify":1704195677777,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","listText":"<a href=\"https://laohu8.com/S/BSQR\">$Bsquare Corp(BSQR)$</a>first time buying this stock? What is its play like? Any potential target?","text":"$Bsquare Corp(BSQR)$first time buying this stock? What is its play like? Any potential target?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/114599550","isVote":1,"tweetType":1,"viewCount":1117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139003284,"gmtCreate":1621570968048,"gmtModify":1704359866140,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>stuck at $18+. What price can it reach?","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>stuck at $18+. What price can it reach?","text":"$Microvision(MVIS)$stuck at $18+. What price can it reach?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/139003284","isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573872079389073","authorId":"3573872079389073","name":"肥仔潜力股","avatar":"https://static.tigerbbs.com/a314146553928a2f422e596fb08cef8f","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573872079389073","idStr":"3573872079389073"},"content":"stuck at $18... no DCA done?","text":"stuck at $18... no DCA done?","html":"stuck at $18... no DCA done?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138732309,"gmtCreate":1621961052901,"gmtModify":1704365230006,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a> Any news/reason for the price finally moving?","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a> Any news/reason for the price finally moving?","text":"$Microvision(MVIS)$ Any news/reason for the price finally moving?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/138732309","isVote":1,"tweetType":1,"viewCount":842,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371896437,"gmtCreate":1618925782129,"gmtModify":1704716970102,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>high short volume. can we see MVIS do a GME?","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>high short volume. can we see MVIS do a GME?","text":"$Microvision(MVIS)$high short volume. can we see MVIS do a GME?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371896437","isVote":1,"tweetType":1,"viewCount":259,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346901742,"gmtCreate":1617977897386,"gmtModify":1704705588046,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>The tiger roars!","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>The tiger roars!","text":"$Tiger Brokers(TIGR)$The tiger roars!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346901742","isVote":1,"tweetType":1,"viewCount":198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":352901402,"gmtCreate":1616846559706,"gmtModify":1704799575350,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"Waiting for Roblox to do a GME!","listText":"Waiting for Roblox to do a GME!","text":"Waiting for Roblox to do a GME!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/352901402","repostId":"2122444907","repostType":4,"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351203768,"gmtCreate":1616595660254,"gmtModify":1704796200331,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.","listText":"The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.","text":"The market is like a story. This has happened for more than a day but news came out later. Feels like a bigger hand is pacing the release of news so that there's some drama/story for the market each day.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/351203768","repostId":"1138591041","repostType":4,"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328403845,"gmtCreate":1615545852887,"gmtModify":1704784374304,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"[OK] ","listText":"[OK] ","text":"[OK]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328403845","repostId":"1199156489","repostType":4,"isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":379334337,"gmtCreate":1618671699629,"gmtModify":1704713974855,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CCIV\">$Churchill Capital Corp IV(CCIV)$</a>anybody knows what are the potential catalysts for this stock to rebound?","listText":"<a href=\"https://laohu8.com/S/CCIV\">$Churchill Capital Corp IV(CCIV)$</a>anybody knows what are the potential catalysts for this stock to rebound?","text":"$Churchill Capital Corp IV(CCIV)$anybody knows what are the potential catalysts for this stock to rebound?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/379334337","isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578631106874889","authorId":"3578631106874889","name":"Starship89","avatar":"https://static.tigerbbs.com/32ff2a09eb9746949c2dd2367dedee47","crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3578631106874889","idStr":"3578631106874889"},"content":"Most probably till we start seeing test drive by public and review. Till now we’ve yet to see any lucid EV on the road other than CEO is driving. It is obvious why it falls so hard.","text":"Most probably till we start seeing test drive by public and review. Till now we’ve yet to see any lucid EV on the road other than CEO is driving. It is obvious why it falls so hard.","html":"Most probably till we start seeing test drive by public and review. Till now we’ve yet to see any lucid EV on the road other than CEO is driving. It is obvious why it falls so hard."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320159889,"gmtCreate":1615048808541,"gmtModify":1704778389346,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/U09.SI\">$AVARGA LIMITED(U09.SI)$</a>Waiting for PL to show his magic power. Be patient.","listText":"<a href=\"https://laohu8.com/S/U09.SI\">$AVARGA LIMITED(U09.SI)$</a>Waiting for PL to show his magic power. Be patient.","text":"$AVARGA LIMITED(U09.SI)$Waiting for PL to show his magic power. Be patient.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320159889","isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159847038,"gmtCreate":1624958412124,"gmtModify":1703848829475,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159847038","repostId":"2147832042","repostType":4,"isVote":1,"tweetType":1,"viewCount":825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126542274,"gmtCreate":1624579973398,"gmtModify":1703840734118,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126542274","repostId":"1160256327","repostType":4,"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119656923,"gmtCreate":1622544455262,"gmtModify":1704185988030,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","listText":"<a href=\"https://laohu8.com/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$been consolidating for so long. Perhaps one more flush tomorrow to collect from contra players before pushing up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119656923","isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107468378,"gmtCreate":1620530058994,"gmtModify":1704344660719,"author":{"id":"3565449260630555","authorId":"3565449260630555","name":"jac_tb","avatar":"https://static.tigerbbs.com/b9fae92f2169c629ed025d1e5eba727c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565449260630555","idStr":"3565449260630555"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>when can I see it green in my portfolio again...","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>when can I see it green in my portfolio again...","text":"$Microvision(MVIS)$when can I see it green in my portfolio again...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/107468378","isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}